Changshan Pharmaceutical: Net profit in the first quarter of 2025 is 3.7826 million yuan.

Changshan Pharmaceutical announced that its operating income for the first quarter of 2025 was 259 million yuan, a decrease of 12.10% compared to the same period last year. Net profit was 3.7826 million yuan, compared to a net loss of 61.6651 million yuan in the same period last year.